1-[3-Iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]ethanone is a heterocyclic compound that belongs to the class of substituted pyrazoles. Pyrazoles are five-membered nitrogen-containing rings that have been widely studied since the late nineteenth century due to their chemical stability, ease of functionalization, and biological activity. Substituted pyrazoles, such as the title compound, are of particular interest in medicinal chemistry because the combination of nitrogen heterocycles with halogen and alkyl substituents can influence receptor binding, enzyme inhibition, and pharmacokinetic properties.
Structurally, this molecule contains a pyrazole ring substituted at the N1 nitrogen with an isopropyl group, at the C3 carbon with an iodine atom, and at the C4 carbon with an ethanone (acetyl) group. The N-alkylation at the pyrazole nitrogen provides steric bulk and increases lipophilicity, while the iodine substituent introduces a heavy atom that can participate in halogen bonding and influence electronic properties. The acetyl group contributes an electrophilic carbonyl functionality, which can undergo further chemical transformations and provides hydrogen-bonding capability when interacting with biological targets.
The synthesis of 1-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]ethanone typically involves constructing the pyrazole ring from appropriately substituted hydrazines and 1,3-dicarbonyl compounds. N-alkylation at the pyrazole nitrogen can be achieved using alkyl halides under controlled conditions. The introduction of iodine at the C3 position is often accomplished via electrophilic halogenation using iodine sources in the presence of oxidizing agents. These synthetic methods allow for regioselective substitution and provide access to high-purity compounds for further chemical or biological applications.
Compounds of this type are widely explored as intermediates in the development of bioactive molecules. Pyrazole derivatives have been investigated for a variety of pharmacological effects, including anti-inflammatory, antimicrobial, antiviral, and anticancer activities. The presence of the iodine atom allows for the design of compounds with improved binding to enzyme active sites or receptor pockets, as halogens can participate in van der Waals interactions, halogen bonding, and modulation of electronic density. The acetyl group can also serve as a reactive handle for the preparation of amides, hydrazones, or other derivatives in drug discovery.
In addition to biological applications, substituted pyrazoles are valuable building blocks in synthetic organic chemistry. The pyrazole core is stable under a wide range of reaction conditions, allowing for further functionalization through cross-coupling reactions, nucleophilic substitution, or condensation reactions. The combination of N-alkyl, halogen, and carbonyl substituents provides chemists with multiple reactive sites to construct complex molecules for research or pharmaceutical applications.
Overall, 1-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]ethanone exemplifies a functionalized pyrazole derivative with structural features that make it suitable for both medicinal chemistry and synthetic applications. The pyrazole scaffold, N-alkylation, halogenation, and carbonyl substitution together create a versatile framework for exploring chemical reactivity, molecular interactions, and the development of biologically active compounds.
References
2018. Encorafenib. Pharmaceutical Substances.
|
![CAS # 1269440-49-4, 1-[3-Iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]ethanone](/structures/1269440-49-4.gif)
GHS07 Warning Details
Discovery and Applications